WO2012017128A3 - Composition à base d'extrait de romarin et de vitamine e et applications de celle-ci - Google Patents

Composition à base d'extrait de romarin et de vitamine e et applications de celle-ci Download PDF

Info

Publication number
WO2012017128A3
WO2012017128A3 PCT/ES2011/070586 ES2011070586W WO2012017128A3 WO 2012017128 A3 WO2012017128 A3 WO 2012017128A3 ES 2011070586 W ES2011070586 W ES 2011070586W WO 2012017128 A3 WO2012017128 A3 WO 2012017128A3
Authority
WO
WIPO (PCT)
Prior art keywords
vitamin
rosemary extract
composition based
menopause
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/ES2011/070586
Other languages
English (en)
Spanish (es)
Other versions
WO2012017128A2 (fr
WO2012017128A1 (fr
Inventor
Enrique De Miguel Del Campo
Guillermo Reglero Rada
Carlota Largo Aramburu
Fornari Reale
Mónica RODRÍGUEZ GARCÍA-RISCO
Laura Jaime De Pablo
Susana Santoyo Diez
Francisco Javier SEÑORANS RODRÍGUEZ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universidad Autonoma de Madrid
Fundacion para la Investigacion Biomedica del Hospital Universitario La Paz
Original Assignee
Universidad Autonoma de Madrid
Fundacion para la Investigacion Biomedica del Hospital Universitario La Paz
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universidad Autonoma de Madrid, Fundacion para la Investigacion Biomedica del Hospital Universitario La Paz filed Critical Universidad Autonoma de Madrid
Publication of WO2012017128A2 publication Critical patent/WO2012017128A2/fr
Publication of WO2012017128A1 publication Critical patent/WO2012017128A1/fr
Publication of WO2012017128A3 publication Critical patent/WO2012017128A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Botany (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention concerne une composition comprenant un extrait de romarin et de la vitamine E, laquelle composition peut être utilisée comme complément alimentaire et pour préparer des compositions pharmaceutiques destinées à réduire les processus inflammatoires et la peroxydation lipidique de manière générale, en particulier les processus associés à la ménopause, et à prévenir et/ou traiter les effets secondaires des rayonnements ionisants.
PCT/ES2011/070586 2011-08-05 Composition à base d'extrait de romarin et de vitamine e et applications de celle-ci Ceased WO2012017128A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES201031225A ES2374482B1 (es) 2010-08-05 2010-08-05 Composición para la reducción de síntomas asociados a la menopausia.
ESP201031225 2010-08-05

Publications (3)

Publication Number Publication Date
WO2012017128A2 WO2012017128A2 (fr) 2012-02-09
WO2012017128A1 WO2012017128A1 (fr) 2012-02-09
WO2012017128A3 true WO2012017128A3 (fr) 2012-03-08

Family

ID=

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040048919A1 (en) * 2002-07-02 2004-03-11 Dreon Darlene M. Compositions and methods for reduction of inflammatory symptoms and/or biomarkers in female subjects
US20070141170A1 (en) * 2005-12-20 2007-06-21 Alcon Manufacturing, Ltd. Composition and methods for inhibiting the progression macular degeneration and promoting healthy vision
US20070253941A1 (en) * 2006-04-28 2007-11-01 Naidu A Satyanarayan Coenzyme Q10, lactoferrin and angiogenin compositions and uses thereof
WO2007141764A1 (fr) * 2006-06-08 2007-12-13 The Iams Company Utilisation d'au moins un polyphénol pour favoriser la santé oculaire
EP1902631A2 (fr) * 2006-09-19 2008-03-26 Institut National de Recherche Agronomique Additif antioxydant naturel d'origine végétale destiné à la nutrition animale
WO2009136410A2 (fr) * 2008-04-19 2009-11-12 Nisarga Biotech Pvt. Ltd. Composition à base de plantes destinée à diminuer l’add/l’adhd, et procédé afférent
US20100048512A1 (en) * 2006-12-01 2010-02-25 National Institute Of Radiological Sciences Radiation protection drug containing tocopherol or tocotrienol compound ester derivative as active ingredient

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040048919A1 (en) * 2002-07-02 2004-03-11 Dreon Darlene M. Compositions and methods for reduction of inflammatory symptoms and/or biomarkers in female subjects
US20070141170A1 (en) * 2005-12-20 2007-06-21 Alcon Manufacturing, Ltd. Composition and methods for inhibiting the progression macular degeneration and promoting healthy vision
US20070253941A1 (en) * 2006-04-28 2007-11-01 Naidu A Satyanarayan Coenzyme Q10, lactoferrin and angiogenin compositions and uses thereof
WO2007141764A1 (fr) * 2006-06-08 2007-12-13 The Iams Company Utilisation d'au moins un polyphénol pour favoriser la santé oculaire
EP1902631A2 (fr) * 2006-09-19 2008-03-26 Institut National de Recherche Agronomique Additif antioxydant naturel d'origine végétale destiné à la nutrition animale
US20100048512A1 (en) * 2006-12-01 2010-02-25 National Institute Of Radiological Sciences Radiation protection drug containing tocopherol or tocotrienol compound ester derivative as active ingredient
WO2009136410A2 (fr) * 2008-04-19 2009-11-12 Nisarga Biotech Pvt. Ltd. Composition à base de plantes destinée à diminuer l’add/l’adhd, et procédé afférent

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
PENG, C.-H. ET AL.: "Supercritical fluid extracts of rosemary leaves exhibit potent anti-inflammation and anti-tumor effects.", BIOSCIENCE, BIOTECHNOLOGY AND BIOCHEMISTRY, vol. 71, no. 9, 2007, pages 2223 - 2232 *

Also Published As

Publication number Publication date
ES2374482A1 (es) 2012-02-17
WO2012017128A2 (fr) 2012-02-09
ES2374482B1 (es) 2012-12-27

Similar Documents

Publication Publication Date Title
WO2008153945A3 (fr) Compositions nutraceutiques de co-cristal
WO2014188276A3 (fr) Compositions d'antioxydants et procédés d'utilisation
HK1205942A1 (en) Compositions, methods, and kits for regulating energy metabolism
WO2010000877A3 (fr) Formulation à base de bisabolol et de [6]-paradol produisant un effet apaisant sur les irritations
WO2012024620A3 (fr) Inhibiteurs de l'autotaxine et leurs utilisations
WO2013177419A3 (fr) Compositions de nanoparticules lipidiques ainsi que procédés de fabrication et procédés d'utilisation de celles-ci
WO2016086206A8 (fr) Compositions probiotiques contenant des clostridiales pour inhiber une inflammation
SG10201406300YA (en) L-ornithine phenyl acetate and methods of making thereof
WO2012074930A3 (fr) Composition à faible éructation et méthodes de traitement et/ou de prévention de maladie cardiovasculaire chez un sujet présentant une allergie/hypersensibilité aux poissons
WO2014057362A3 (fr) Compositions d'oméga 3
WO2012077120A3 (fr) Formulations naturelles
MX367861B (es) Una composición nutricional para usarse en la preservación del músculo esquelético.
WO2013150386A3 (fr) Compositions comprenant des acides gras oméga-3 et de la vitamine d destinées à lutter contre l'acné vulgaire et/ou l'eczéma, et méthodes et utilisations associées
PH12017500641A1 (en) Nutritional compositions comprising an oxidizablecomponent and water-soluble plant extract
HK1212251A1 (en) Topical compositions and methods of use
EP3878445A3 (fr) Formulations d'acamprosate, leurs procédés d'utilisation et combinaisons les comprenant
WO2011104652A3 (fr) Compositions vétérinaires
PH12014500859A1 (en) Pharmaceutical compositions comprising dgla and/or 15-hetre and methods of use thereof
WO2015067336A3 (fr) Polymères conjugués
EP2575842A4 (fr) Composition comprenant l'extrait de physalis alkekengi var. francheti hort en tant que principe actif pour la prévention et le traitement de maladies inflammatoires
AU2012345659A8 (en) Acamprosate formulations, methods of using the same, and combinations comprising the same
WO2013100718A3 (fr) Composition pharmaceutique permettant de prévenir ou de traiter des maladies inflammatoires ou l'asthme, contenant un extrait de lagerstroemia ovalifolia ou une fraction de celle-ci en tant que principe actif
WO2012134172A3 (fr) Composition contenant, comme ingrédient actif, une fraction d'acétate d'éthyle de schisandra chinensis baill, ou wuweizisu c séparée de la fraction, pour prévenir ou traiter l'obésité
BR112012029988A2 (pt) composição antioxidante sinérgica
WO2013037985A8 (fr) Combinaisons pharmaceutiques contenant des conjugués anti-inflammatoire- antioxydant et destinées à être utilisées en vue du traitement d'affections métaboliques

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11814154

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 11814154

Country of ref document: EP

Kind code of ref document: A2